Inventor · disambiguated record
Carsten Möller
Also filed as: MOELLER CARSTEN · MOLLER CARSTEN · MüLLER CARSTEN
11 granted patents·4 pending applications·18 citations·filing 2007–2018
84Inventor score
Files withKLAR ULRICH5SCHWEDE WOLFGANG4BAYER IP GMBH2BAYER SCHERING PHARIMA AKTIENGESELL SCHAFT1Bayer Pharma AG1
Top patents by PatentIndex Score
15 records- 0186US10155004B217-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseasesBAYER IP GMBH·Filed 2017·Granted Dec 18, 2018·4 cites·3 claims
- 0285US8278469B217-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseasesSCHWEDE WOLFGANG·Filed 2011·Granted Oct 2, 2012·7 cites·2 claims
- 0380US9717739B217-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseasesBAYER IP GMBH·Filed 2015·Granted Aug 1, 2017·2 cites·14 claims
- 0474US9085603B2Progesterone receptor antagonistsSCHWEDE WOLFGANG·Filed 2011·Granted Jul 21, 2015·3 cites·15 claims
- 0570US9109004B2Progesterone receptor antagonistsSCHWEDE WOLFGANG·Filed 2011·Granted Aug 18, 2015·2 cites·10 claims
- 0650US2012149670A117-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseasesSCHWEDE WOLFGANG·Filed 2010·Application pending·0 cites
- 0747US2011112057A1Sequential administration of 20,20,21,21,21-pentafluoro-17-hydroxy-11Beta-[4-(hydroxyacetyl)phenyl]-19-nor-17Alpha-pregna-4,9-dien-3-one and one or more progestogens for the treatment of gynaecological disordersBAYER SCHERING PHARIMA AKTIENGESELL SCHAFT·Filed 2009·Application pending·0 cites
- 0838US9206219B217-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseasesKLAR ULRICH·Filed 2010·Granted Dec 8, 2015·0 cites·12 claims
- 0938US9096640B217-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-methylene oxyalkylene aryl derivatives, process for preparation thereof, and use thereof for treatment of diseasesKLAR ULRICH·Filed 2010·Granted Aug 4, 2015·0 cites·12 claims
- 1037US9156877B217-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzylidene derivatives, methods for the production thereof and use thereof for treating diseasesKLAR ULRICH·Filed 2010·Granted Oct 13, 2015·0 cites·10 claims
- 1137US9102701B217-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-ethynylphenyl derivatives, methods for the production thereof and use thereof for treating diseasesKLAR ULRICH·Filed 2010·Granted Aug 11, 2015·0 cites·10 claims
- 1237US9096639B217-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene phenyl derivatives, methods for the production thereof and use thereof for treating diseasesKLAR ULRICH·Filed 2010·Granted Aug 4, 2015·0 cites·20 claims
- 1337US2009238836A1Hip kinase for fertility controlSACHER FRANK·Filed 2007·Application pending·0 cites
- 1436US2013252890A16,7-dihydro-5h-benzo[7]annulene derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and the use thereof for production of medicamentsWINTERMANTEL TIM·Filed 2011·Application pending·0 cites
- 1535US10485808B2Selective progesterone receptor modulators (SPRM) and stabilized estrogen level in patientBayer Pharma AG·Filed 2018·Granted Nov 26, 2019·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Carsten Möller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →